We assessed some melanoma stem cell markers, such as CD133, CD166, CD271, Nestin, ABCB5, and ALDH activity by flow cytometry, and there was no evidence indicative of GM2/GD2 involvement in stemness (Fig. S3A–F). The gene discussed is ALCAM; the disease is melanoma.